Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
NZ$7.58 M
Marketcap
$0.57
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Mallinckrodt Pharmaceuticals (MNK)

Earnings in 2023 (TTM): -NZ$1.89 Billion

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current earnings are NZ$1.93 Billion. In 2022 the company made an earning of -NZ$2.46 Billion a decrease over its 2021 earnings that were of -NZ$1.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$1.89 Billion-23.1%
2022 -NZ$2.46 Billion76.14%
2021 -NZ$1.4 Billion-13.63%
2020 -NZ$1.62 Billion-39.63%
2019 -NZ$2.67 Billion-61.51%
2018 -NZ$6.94 Billion-6812.18%
2017 NZ$0.10 B-185.79%
2016 -NZ$0.13 Billion-131.27%
2015 NZ$0.38 B-166.82%
2014 -NZ$0.58 Billion-319.69%
2013 NZ$0.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$29.24 B-1,616.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion-81.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.48 Billion-75.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$14.25 B-839.07%๐Ÿ‡บ๐Ÿ‡ธ USA